Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 353

1.

Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy.

Fukui S, Nakamura H, Takahashi Y, Iwamoto N, Hasegawa H, Yanagihara K, Nakamura T, Okayama A, Kawakami A.

BMC Immunol. 2017 Feb 3;18(1):7. doi: 10.1186/s12865-017-0191-2.

2.

Experimental Evaluation of Energy Efficiency for a Soft Wearable Robotic Suit.

Jin S, Iwamoto N, Hashimoto K, Yamamoto M.

IEEE Trans Neural Syst Rehabil Eng. 2016 Oct 12. doi: 10.1109/TNSRE.2016.2613886. [Epub ahead of print]

PMID:
28113402
3.

Superior cluneal nerve entrapment neuropathy and gluteus medius muscle pain: Their effect on very old patients with low back pain.

Kokubo R, Kim K, Isu T, Morimoto D, Iwamoto N, Kobayashi S, Morita A.

World Neurosurg. 2016 Oct 27. pii: S1878-8750(16)31085-3. doi: 10.1016/j.wneu.2016.10.096. [Epub ahead of print]

PMID:
27989968
4.

Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years.

Fukui S, Iwamoto N, Shimizu T, Umeda M, Nishino A, Koga T, Kawashiri SY, Ichinose K, Hirai Y, Tamai M, Nakamura H, Aramaki T, Iwanaga N, Izumi Y, Origuchi T, Migita K, Ueki Y, Sato S, Kawakami A.

Arthritis Res Ther. 2016 Dec 13;18(1):293.

5.
6.

Synovitis of sternoclavicular and peripheral joints can be detected by ultrasound in patients with SAPHO syndrome.

Umeda M, Kawashiri SY, Nishino A, Koga T, Ichinose K, Michitsuji T, Shimizu T, Fukui S, Nakashima Y, Hirai Y, Iwamoto N, Aramaki T, Tamai M, Nakamura H, Origuchi T, Ueki Y, Kawakami A.

Mod Rheumatol. 2016 Dec 9:1-5. [Epub ahead of print]

PMID:
27846749
7.

Assessment of both articular synovitis and tenosynovitis by ultrasound is useful for evaluations of hand dysfunction in early rheumatoid arthritis patients.

Nishino A, Kawashiri SY, Shimizu T, Umeda M, Fukui S, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Nagata Y, Maeda T, Aoyagi K, Kawakami A.

Mod Rheumatol. 2016 Nov 15:1-4. [Epub ahead of print]

PMID:
27830970
8.

Experimental Evaluation of Energy Efficiency for a Soft Wearable Robotic Suit.

Jin S, Iwamoto N, Hashimoto K, Yamamoto M.

IEEE Trans Neural Syst Rehabil Eng. 2016 Oct 12. [Epub ahead of print]

PMID:
27740489
9.

Successful treatment of palmoplantar pustulosis with rheumatoid arthritis, with tofacitinib: Impact of this JAK inhibitor on T-cell differentiation.

Koga T, Sato T, Umeda M, Fukui S, Horai Y, Kawashiri SY, Iwamoto N, Ichinose K, Nakamura H, Kawakami A.

Clin Immunol. 2016 Dec;173:147-148. doi: 10.1016/j.clim.2016.10.003. No abstract available.

PMID:
27720846
10.

Antineutrophilic cytoplasmic antibody-associated vasculitis with hypocomplementemia has a higher incidence of serious organ damage and a poor prognosis.

Fukui S, Iwamoto N, Umeda M, Nishino A, Nakashima Y, Koga T, Kawashiri SY, Ichinose K, Hirai Y, Tamai M, Nakamura H, Origuchi T, Sato S, Kawakami A.

Medicine (Baltimore). 2016 Sep;95(37):e4871. doi: 10.1097/MD.0000000000004871.

11.

Ultrasound disease activity of bilateral wrist and finger joints at three months reflects the clinical response at six months of patients with rheumatoid arthritis treated with biologic disease-modifying anti-rheumatic drugs.

Kawashiri SY, Nishino A, Shimizu T, Umeda M, Fukui S, Nakashima Y, Suzuki T, Koga T, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Aoyagi K, Kawakami A.

Mod Rheumatol. 2016 Sep 1:1-5. [Epub ahead of print]

PMID:
27585858
12.

Caveolin-1 facilitates internalization and degradation of ABCA1 and probucol oxidative products interfere with this reaction to increase HDL biogenesis.

Lu R, Tsuboi T, Okumura-Noji K, Iwamoto N, Yokoyama S.

Atherosclerosis. 2016 Oct;253:54-60. doi: 10.1016/j.atherosclerosis.2016.08.025.

PMID:
27579791
13.

Giant Cell Arteritis which Developed after the Administration of Granulocyte-colony Stimulating Factor for Cyclic Neutropenia.

Umeda M, Ikenaga J, Koga T, Michitsuji T, Shimizu T, Fukui S, Nishino A, Nakasima Y, Kawashiri SY, Iwamoto N, Ichinose K, Hirai Y, Tamai M, Nakamura H, Origuchi T, Kawakami A.

Intern Med. 2016;55(16):2291-4. doi: 10.2169/internalmedicine.55.6704.

14.

Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells.

Merkle R, Steiert B, Salopiata F, Depner S, Raue A, Iwamoto N, Schelker M, Hass H, Wäsch M, Böhm ME, Mücke O, Lipka DB, Plass C, Lehmann WD, Kreutz C, Timmer J, Schilling M, Klingmüller U.

PLoS Comput Biol. 2016 Aug 5;12(8):e1005049. doi: 10.1371/journal.pcbi.1005049.

15.

Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.

Kawashiri SY, Nishino A, Suzuki T, Nakashima Y, Horai Y, Ueki Y, Aramaki T, Fujikawa K, Nakashima M, Okada A, Migita K, Mizokami A, Matsuoka N, Mine M, Sakito S, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Aoyagi K, Eguchi K, Kawakami A.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):808-812.

PMID:
27384149
16.

[Abatacept].

Iwamoto N, Kawakami A.

Nihon Rinsho. 2016 Jun;74(6):968-73. Review. Japanese.

PMID:
27311187
18.

The Severity of Takayasu Arteritis Is Associated with the HLA-B52 Allele in Japanese Patients.

Origuchi T, Fukui S, Umeda M, Nishino A, Nakashima Y, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Kawakami A.

Tohoku J Exp Med. 2016;239(1):67-72. doi: 10.1620/tjem.239.67.

19.

Validated LC-MS/MS analysis of immune checkpoint inhibitor Nivolumab in human plasma using a Fab peptide-selective quantitation method: nano-surface and molecular-orientation limited (nSMOL) proteolysis.

Iwamoto N, Shimada T, Terakado H, Hamada A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jun 15;1023-1024:9-16. doi: 10.1016/j.jchromb.2016.04.038.

20.
Items per page

Supplemental Content

Loading ...
Support Center